pwshub.com

Walgreens to shutter 1,200 stores as CEO Wentworth seeks turnaround

Walgreens Boots Alliance (WBA) said on Tuesday it would shut 1,200 stores over the next three years as new CEO Tim Wentworth plots a turnaround at the struggling pharmacy chain operator hit by sluggish consumer spending and low drug reimbursement rates.

Walgreens stock rose 7% before the bell on Tuesday.

The company also narrowly beat Wall Street's lowered estimates for fourth-quarter adjusted profit, and forecast fiscal-year earnings that were mostly in-line with expectations.

Pharmacy chains are facing their most turbulent time in recent history as consumers avoid high-priced grocery items and pressures mount on payments they receive from drug middlemen for filling prescriptions.

As a result, Walgreens' stock is trading near 30-year lows and down 65% this year, making it the worst performing stock on the S&P 500 index.

CEO Wentworth has unveiled a series of changes since taking on the top job last year, including the removal of multiple mid-level executives and a $1 billion cost-cutting program.

"This turnaround will take time, but we are confident it will yield significant financial and consumer benefits over the long term," said Wentworth in a statement.

The closures were announced in June but the company had not disclosed the number of affected stores at that time. It had over 8,000 stores in the United States as of Aug. 31 last year.

In the fourth quarter of its fiscal year 2024, Walgreens said it recorded impairment charges on the goodwill of home care provider CareCentrix and equity investment in China.

Excluding those items and other charges, the company earned 39 cents per share on an adjusted basis. Analysts had expected a profit of 36 cents per share, according to data compiled by LSEG.

Comparable retail sales fell 1.7%, hurt by "a challenging retail environment". Sales of groceries and other items at Walgreens stores have been hit as consumers increasingly hunt for bargains and shun higher-priced items.

For fiscal 2025, Walgreens said it expects adjusted earnings of $1.40 to $1.80 per share, versus estimates of $1.73 per share.

(Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty)

Source: finance.yahoo.com

Related stories
1 month ago - Walgreens has agreed to pay $106 million to settle lawsuits that alleged the pharmacy chain submitted false payment claims with government health care programs for prescriptions that were never dispensed. The settlement announced on...
1 hour ago - Walgreens will close about 1,200 locations over the next three years as the drugstore chain seeks to turnaround a struggling U.S. business that contributed to a $3 billion quarterly loss. The company said Tuesday that about 500 store...
1 month ago - When a company is in a tough financial situation, all options are on the table. For the sake of keeping its operations afloat and ensuring its...
2 weeks ago - With its stock trading at multiyear lows that have led to a nearly 12% dividend yield, Walgreens Boots Alliance (NASDAQ: WBA) has likely popped up...
1 month ago - If you're holding shares of Walgreens Boots Alliance (NASDAQ: WBA) in hopes of it turning around promptly, I think that now is the time to cut your...
Other stories
34 minutes ago - Anthony Holmes thought he had struck gold when he joined the thousands of Americans flocking to Florida during the pandemic. In 2021, Holmes left Virginia, buying a five-bedroom home in a gated Tampa community for $550,000. After...
35 minutes ago - (Bloomberg) -- Charles Schwab Corp. jumped in early New York trading after reporting earnings per share that topped analyst estimates and curbing some of its expensive debt — a sign the firm has moved past a bout of turbulence last year....
35 minutes ago - Bank of America Corp (NYSE:BAC) reported a third-quarter fiscal 2024 net income of $6.9 billion and EPS of $0.81, beating the analyst consensus estimate of $0.77. Net income fell 12% year-on-year due to higher provisions for loan losses...
35 minutes ago - On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating the consensus of $2.21. The pharmaceutical giant reported sales of $22.47 billion, up 5.2% year over year and...
35 minutes ago - (Bloomberg) -- UnitedHealth Group Inc. shares fell in early trading Tuesday after the company lowered the top end of its forecast, a rare move for the insurance giant that has often withstood pressures that hurt its competitors.Most Read...